Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 1/20 | 0.69 |
| ▸ | CNR1 | P21554 | 5/20 | 0.61 |
| ▸ | CNR2 | P34972 | 3/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.60 |
| ▸ | HPGD | P15428 | 2/20 | 0.60 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | BLM | P54132 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | THRB | P10828 | 1/20 | 0.60 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.59 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.54 |
| ▸ | FAAH | O00519 | 1/20 | 0.54 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6072553 | 0.96 | CNR2 (0.64) | MGLLCNR1CNR2ALDH1A1MAPT | |
| SCHEMBL6072564 | 0.96 | CNR2 (0.64) | MGLLCNR1CNR2ALDH1A1MAPT | |
| SCHEMBL12179602 | 0.95 | MGLL (0.68) | MGLLCNR1CNR2ALDH1A1MAPT | |
| SCHEMBL14759657 | 0.95 | MGLL (0.68) | MGLLCNR1CNR2ALDH1A1MAPT | |
| SCHEMBL12179613 | 0.91 | EPHX2 (0.61) | MGLLCNR1CNR2ALDH1A1MAPT | |
| SCHEMBL14760438 | 0.91 | EPHX2 (0.61) | MGLLCNR1CNR2ALDH1A1MAPT | |
| SCHEMBL12232837 | 0.89 | EPHX2 (0.60) | MGLLCNR1CNR2ALDH1A1MAPT | |
| SCHEMBL18209370 | 0.89 | EPHX2 (0.60) | MGLLCNR1CNR2ALDH1A1MAPT | |
| SCHEMBL19876897 | 0.89 | ALDH1A1 (0.61) | MGLLCNR1ALDH1A1MAPTHPGD | |
| SCHEMBL24573726 | 0.88 | EPHX2 (0.63) | MGLLCNR1CNR2ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190133948-A1 | FUSOGENIC COMPOUNDS FOR DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES | NITTO DENKO CORPORATION (JP) | 2019-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190133948-A1 | FUSOGENIC COMPOUNDS FOR DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES | FUS, NSF, PGF | MGLL 857/4885CNR1 3644/4885CNR2 4024/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.